NASDAQ:MYSE Myseum (MYSE) Stock Price, News & Analysis $1.79 +0.14 (+8.73%) Closing price 03:59 PM EasternExtended Trading$1.79 0.00 (-0.22%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Myseum Stock (NASDAQ:MYSE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Myseum alerts:Sign Up Key Stats Today's Range$1.64▼$1.8750-Day Range$1.33▼$3.8152-Week Range$1.31▼$5.77Volume203,127 shsAverage Volume3.24 million shsMarket Capitalization$7.75 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Myseum, Inc. (formerly DatChat Inc.) is a security- and privacy-first social media and technology company focused on innovative and creative user platforms. Its flagship platform is Myseum, your Free Timeless Digital Shoebox Social Network that makes it easier to share your photos and videos both today, and for generations to come. Read More Myseum Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks5th Percentile Overall ScoreMYSE MarketRank™: Myseum scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingMyseum has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageMyseum has only been the subject of 1 research reports in the past 90 days.Read more about Myseum's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Myseum is -1.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Myseum is -1.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMyseum has a P/B Ratio of 1.23. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.46% of the float of Myseum has been sold short.Short Interest Ratio / Days to CoverMyseum has a short interest ratio ("days to cover") of 0.02, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Myseum has recently increased by 321.95%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMyseum does not currently pay a dividend.Dividend GrowthMyseum does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.22 News SentimentMyseum has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.91 average news sentiment score of Financial Services companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Myseum this week, compared to 2 articles on an average week.Search Interest16 people have searched for MYSE on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added Myseum to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Myseum insiders have not sold or bought any company stock.Percentage Held by Insiders7.63% of the stock of Myseum is held by insiders.Percentage Held by Institutions0.92% of the stock of Myseum is held by institutions.Read more about Myseum's insider trading history. Receive MYSE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Myseum and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MYSE Stock News HeadlinesMyseum.AI (MYSE) Lands A Key AMD Partnership As Its AI Ambitions ExpandMay 13 at 3:57 AM | insidermonkey.comMyseum.AI to Present at 16th Annual LD Micro Invitational Conference; Picture Party Named Official Private Social Media PlatformMay 8, 2026 | globenewswire.comPeptide Company Lands Exclusive MMA Wellness PartnershipA publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.May 14 at 1:00 AM | The Tomorrow Investor (Ad)Myseum.AI Appoints Ian Goldberg as Head of Marketing, Partnerships & MonetizationApril 28, 2026 | globenewswire.comMyseum.AI Expands At-the-Market Equity Offering ProgramApril 26, 2026 | theglobeandmail.comMyseum.AI to Debut Picture Party for Couples at the Florida Bridal & Wedding ExpoApril 24, 2026 | globenewswire.comMyseum.AI, Inc.: Myseum.AI Accepted into Advanced Micro Devices AI Developer ProgramApril 18, 2026 | finanznachrichten.deAI name changes serve as a reliable red flag for short-selling fundsApril 17, 2026 | afr.comSee More Headlines MYSE Stock Analysis - Frequently Asked Questions How have MYSE shares performed this year? Myseum's stock was trading at $1.71 at the beginning of the year. Since then, MYSE shares have increased by 2.9% and is now trading at $1.76. How were Myseum's earnings last quarter? Myseum, Inc. (NASDAQ:MYSE) released its quarterly earnings data on Thursday, November, 13th. The company reported ($0.28) EPS for the quarter. When did Myseum's stock split? Myseum shares reverse split before market open on Wednesday, September 20th 2023.The 1-10 reverse split was announced on Tuesday, September 19th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, September 19th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Myseum? Shares of MYSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/13/2025Today5/14/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (6d) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 6 days, MYSE's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinancial Services Industry Internet Content & Information Sub-IndustryCommunication Current SymbolNASDAQ:MYSE Previous SymbolNASDAQ:MYSE CIK1648960 Webwww.myseum.co Phone+972-73-286-4635FaxN/AEmployees10Year FoundedN/AProfitability EPS (Trailing Twelve Months)($1.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$2.61 million Net MarginsN/A Pretax Margin-955,454.56% Return on Equity-75.35% Return on Assets-66.03% Debt Debt-to-Equity RatioN/A Current Ratio4.29 Quick Ratio4.29 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.43 per share Price / Book1.25Miscellaneous Outstanding Shares4,320,000Free Float3,994,000Market Cap$7.75 million OptionableNot Optionable Beta2.02 The 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:MYSE) was last updated on 5/14/2026 by MarketBeat.com Staff. From Our PartnersOne coin wired into Elon's visionThe SpaceX IPO is projected to raise $75 billion in a single day... When that happens, the insiders who cashed...Crypto 101 Media | SponsoredBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...Weiss Ratings | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredPeptide Company Lands Exclusive MMA Wellness PartnershipA publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...The Tomorrow Investor | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredTengu is coming (prepare for June 16)A data leak exposed the code name of an AI breakthrough called Project Tengu - and in just six days, it erased...Chaikin Analytics | SponsoredThe system holding the dollar together is gone…Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myseum, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Myseum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
